RecruitingPhase not listedNCT06297291
Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
Kansas City, MO · +45 more sites
Hypertension clinical trials in Kansas City, MO
8 recruiting hypertension studies with a site in Kansas City, MO.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Kansas City, MO · +270 more sites
RecruitingPhase 1 / Phase 2NCT07123779
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Sponsor: 35Pharma Inc
Kansas City, MO · +1 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +130 more sites
RecruitingNot applicableNCT06559891
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Sponsor: SoniVie Inc.
Kansas City, MO · +33 more sites
RecruitingNot applicableNCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
Sponsor: Alcon Research
Chesterfield, MO · Kansas City, MO · +20 more sites
RecruitingPhase not listedNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Sponsor: Duke University
Kansas City, MO · +49 more sites
RecruitingPhase 4NCT07209410
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
Sponsor: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Kansas City, MO
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.